Afghanistan vs Peru: The number of people with susceptibility test result for rifampicin
Afghanistan
17,443
in 2021
Peru
13,453
in 2021
Afghanistan rank
16th
Peru rank
18th
The number of people with susceptibility test result for rifampicin over time
- Afghanistan
- Peru
How they compare
Afghanistan currently reports 17,443 against 13,453 in Peru, a difference of 3,990.
That makes Afghanistan's figure about 1.3 times Peru's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Peru ahead.
Afghanistan ranks 16th and Peru ranks 18th of 155 countries.
Across the 2 decades both report, Afghanistan averaged higher in 1 and Peru in 1.
Head to head by decade
| Decade | Afghanistan | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6,121 | 13,485 | 7,364 | Peru |
| 2020s | 13,849 | 11,518 | 2,331 | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Afghanistan or Peru?
- Afghanistan, at 17,443 against 13,453 in Peru as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Afghanistan and Peru?
- 3,990, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Peru?
- 5 years are reported by both, from 2017 to 2021.
- How do Afghanistan and Peru rank globally for the number of people with susceptibility test result for rifampicin?
- Afghanistan ranks 16th and Peru ranks 18th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.